Compare Canopy Growth Corp (CGC) vs Boston Beer Company Inc (SAM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Canopy Growth Corp vs Boston Beer Company Inc — how do they compare? Canopy Growth Corp trades at $0.96 (market cap $398.46M), while Boston Beer Company Inc trades at $168.61 (market cap $1.76B). The key difference: Boston Beer Company Inc is far larger — about 4.4× Canopy Growth Corp's market cap. Which is the better fit depends on your goals.
| CGC | SAM | |
|---|---|---|
Market Cap | $398.46M | $1.76B |
Sector | Health | Consumer Staples |
52-Week High | $1.92 | $260.05 |
52-Week Low | $0.86 | $161.08 |
Enterprise Value | $337.90M | $1.63B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Canopy Growth (CGC) trades at $0.96, down 1.15% on the day, with a mixed technical picture showing a bullish overall signal but bearish moving averages. The company reported a net loss of $598.12 million in 2025, with revenue declining to $269 million, though recent quarterly earnings showed one beat and two misses against expectations. Cash flow remains negative, but the balance sheet shows improving debt-to-asset ratios, down to 33.13% in 2025 from 53.61% in 2023.
The outlook is cautious; while cost-cutting and restructuring efforts are underway, profitability remains elusive, and the stock faces risks including potential delisting due to low share price. Analyst sentiment is divided, with 33% recommending buy, 41% hold, and 26% sell. Investors should weigh the potential for a turnaround against significant operational and regulatory challenges in the cannabis sector.
Boston Beer Company (SAM) trades at $172.39, down 2.49% on the day, with mixed technical signals showing bearish moving averages but neutral oscillators. Fundamentally, the company reported strong 2025 results with $108M net income and positive cash flow, but faces headwinds with negative 2026 profit margin projections. Recent news highlights innovation in Beyond Beer products and marketing initiatives, though Q1 2026 earnings missed expectations and volume growth concerns persist.
The stock presents a cautious opportunity with analyst consensus target of $213.50 offering 24% upside, but investors face risks from declining volumes, margin pressure, and competitive threats. While cash flow remains positive and valuation ratios appear reasonable, the negative 2026 earnings outlook and bearish technical momentum warrant careful monitoring of upcoming Q2 results and brand performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Canopy Growth Corp
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →About Boston Beer Company Inc
Boston Beer is a leader in U.S. high-end malt beverages and adjacent categories, with strong positions in craft beer, hard cider, and hard seltzer. The firm sells an array of flavor variants and package sizes, predominantly centered around four priority brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly Hard Seltzer. Its drinks are produced in both company-owned breweries as well as through third-party contract arrangements, and while the company primarily goes to market through independent wholesalers (as mandated by law), it operates a fairly large salesforce to induce demand across the value chain (distributors, retailers, and drinkers). The preponderance of revenue is generated domestically.
Read more on SAM →
